scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "PEOPLE with schizophrenia"

1 - 10 of 25,794 results for
 "PEOPLE with schizophrenia"
Results per page:

Clinical correlates of regional gray matter volumes in schizophrenia: A structural magnetic resonance imaging study.

Publication Type: Academic Journal

Source(s): Industrial Psychiatry Journal. Jul-Dec2022, Vol. 31 Issue 2, p282-292. 11p.

Abstract: Objectives: The objective of this study is to investigate the correlation between the regional gray matter volumes and length of Para Cingulate Sulcus (PCS) with the clinical profile of patients with schizophrenia. Materials and Methods: In this hospit...

View details

The appraisal-distress relationship of auditory hallucinations in patients with schizophrenia: The moderating role of metacognitive beliefs.

Publication Type: Academic Journal

Source(s): Industrial Psychiatry Journal. Jul-Dec2022, Vol. 31 Issue 2, p248-254. 7p.

Abstract: Background: Appraisal of hallucinatory voices plays a significant role in anxiety and depression among patients with auditory hallucinations. Metacognitive beliefs are also associated with psychological distress in schizophrenia patients. However, ther...

View details

Comparison of cognition and alexithymia in patients of schizophrenia with and without comorbid alcohol use: A cross-sectional exploratory study.

Publication Type: Academic Journal

Source(s): Industrial Psychiatry Journal. Jul-Dec2022, Vol. 31 Issue 2, p267-275. 9p.

Abstract: Background: Cognitive impairment and alexithymia are commonly associated with schizophrenia and alcohol use disorder independently. Both can lead to poor prognosis and recovery. In patients with dual diagnosis, this association can be more prevalent an...

View details

Cognitive Symptoms in Patients with Schizophrenia at the Psychiatric Ward and Outpatient Clinic in Sulaimani.

Publication Type: Academic Journal

Source(s): Arab Journal of Psychiatry. Nov2022, Vol. 33 Issue 2, p157-167. 11p.

Abstract: الأهداف:تعتبر الأعراض المعرفية سمة مركزية لمرضى الفصام في عديد من جوانب الادراكية المعطلة. إن انتشار الأعراض المعرفية لدى مرضى الفصام في جميع أنحاء العالم معروفجيدًا،ولكن في كردستان العراق-مدينة السليمانية لا يُعرف الكثير عنه. أجريت هذه الدراسة لتقدير ...

View details

Response to Comment on "An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia".

Publication Type: Academic Journal

Source(s): PharmacoEconomics. Dec2022, Vol. 40 Issue 12, p1265-1267. 3p.

Abstract: While we acknowledge that the AL 441 mg dose may be used for all persons taking AL (not just those who cannot tolerate higher doses), it remains true that this dose is used less often in clinical practice (based on IQVIA prescription data) and may be u...

View details

Evaluation of major treatment failure in patients with recent-onset schizophrenia or schizophreniform disorder: A post hoc analysis from the Disease Recovery Evaluation and Modification (DREaM) study.

Publication Type: Academic Journal

Source(s): Schizophrenia Research. Oct2022, Vol. 248, p58-63. 6p.

Abstract: Objective: A post hoc analysis of the Disease Recovery Evaluation and Modification (DREaM) study was conducted to evaluate time to first major treatment failure (ie, arrest/incarceration or psychiatric hospitalization) in participants with recent-onset...

View details

Comment on "An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia".

Publication Type: Academic Journal

Source(s): PharmacoEconomics. Dec2022, Vol. 40 Issue 12, p1261-1263. 3p.

Abstract: All approved AL doses result in stable exposures that fall within the range of concentrations associated with the known efficacy of the AL 441 mg monthly and 882 mg monthly regimens [[6], [16]]. Furthermore, Piena et al. included AL 1064 mg every 6 wee...

View details

Virtual Reality Therapy for the Negative Symptoms of Schizophrenia (V-NeST): A pilot randomised feasibility trial.

Publication Type: Academic Journal

Source(s): Schizophrenia Research. Oct2022, Vol. 248, p50-57. 8p.

Abstract: Background: Negative symptoms are typically observed in people with schizophrenia and indicate a loss or reduction of normal function (e.g. reduced motivation and affect display). Despite obstructing people's recovery, intervention development has rece...

View details

Dysfunction of mitochondria and GABAergic interneurons in the anterior cingulate cortex of individuals with schizophrenia.

Publication Type: Academic Journal

Source(s): Neuroscience Research. Dec2022, Vol. 185, p67-72. 6p.

Abstract: Here we re-analyze RNA-sequencing data from the anterior cingulate cortex (ACC) of SZ patients using recent methods to improve accuracy and sensitivity of results, such as the quality surrogate variable analysis (qSVA) method and the derfinder R packag...

View details
sponsored